Top of this page
Skip navigation, go straight to the content

Our Company

Disease Areas

Our Science

UCB Worldwide

 Search

Our Products

Newsroom

Patients

Investors

FOLLOW US ON
© 2007 – 2018 UCB S.A., Belgium. All rights reserved.
Newsroom • Overview

Newsroom

Press Release

Transparency notifications BlackRock, Inc.12 Dec 2018

Transparency notifications BlackRock, Inc.

Read more
UCB announces approval of VIMPAT® in China02 Dec 2018

UCB announces approval of VIMPAT® in China

Read more
UCB and Amgen Announce FDA Advisory Committee Meeting to review EVENITY™ (Romosozumab) for the Treatment of Osteoporosis in Postmenopausal Women at High Risk for Fracture30 Nov 2018

UCB and Amgen Announce FDA Advisory Committee Meeting to review …

Read more
View all Subscribe

UCB Stories

general picutre of neurology content 3 Dec 2018

Starting from a patient perspective focuses epilepsy treatment progress …

Read more
picture of green strategy 26 Nov 2018

Making our packaging ‘greener’

Read more
general picture of epilepsy 20 Nov 2018

UCB’s commitment to epilepsy

Read more
View all Subscribe

Social Media

 

Resources

Access our media image selection or contact us for particular requests.

 

Contact

The UCB media relations team responds to calls and emails from professional journalists only.